FinancingLiving therapy: Microbial immunotherapy of...Exeliom Biosciences, a French company focused on the microbiome-immunomodulation axis to develop next-generation immunotherapies, has announced the closing of its €24m (US$26m) Series A financing to … more ➔
Novel FoodDutch go first: pre-approval tastings of c...It is just announced that it will soon be possible to taste farmed meat and seafood in the Netherlands under controlled conditions. The Dutch government, in collaboration with cultured meat producers … more ➔
EU, green deal, new genome technologies, NGT, plant, proposal, regulation EU Regulation of Genome Editing in Plants...A long-awaited draft regulation from the EU Commission’s DG Sante to deregulate the authorisation, risk assessment and labelling of a whole range of new genetically modified organisms (GMOs) has been … more ➔
financingDutch NLC has €20m in first close of new...Dutch venture builder NLC has announced a €20m first close for its new Health Impact Fund, from which it will invest in 40 startups, both new investments and follow-on. It’s targeting a final close … more ➔
financingFrench Carthera closes €37.5m Series B f...Carthera, a Sorbonne spin-off and developer of an innovative ultrasound-based medical device for the treatment of a wide range of brain disorders, today announced the successful completion of its €37.5m … more ➔
M&ADonaldson Acquires Belgian Univercells Tec...Donaldson Company, Inc. (NYSE: DCI), a heritage provider of innovative filtration products and solutions, announced the acquisition of Univercells Technologies (Belgium), a global provider of innovative … more ➔
financingGleamer raises €27m in Series B funding...French AI-powered radiography diagnostics specialist Gleamer SAS has raises €27m in Series B round to expand its portfolio and accelerate its expansion. more ➔
Joint ventureCentogene and Lifera kick-off joint ventur...Multi-omics diagnostics specialist Centogene NV has received €30m to form a joint venture with PIF-owned pharmaceutical company Lifera in Saudi-Arabia. more ➔
financingAstraveus SAS bags €16.5m in seed financ...French cell and gene therapy manufacturing specialist Astraveus SAS had raises €16.5m in seed money to advance its automated, microfluidic Cell and Gene Therapy manufacturing platform. more ➔
New BIOTECH insight newsletter outBreaking news from biotechnology and the German stock market are in the focus of the new issue of BIOTECH Insight, the newsletter of Deutsche Börse AG. more ➔
